Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...

Retinal imaging during ROP screening can predict bronchopulmonary dysplasia and pulmonary hypertension in preterm infants, ...

CBT-004 is a novel, preservative-free ophthalmic solution targeting VEGF and PDGF receptors to treat vascularized pinguecula. Phase 2 trial results showed significant improvements in conjunctival ...

The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...

From artificial intelligence and IOL innovation to biosimilars, geographic atrophy, and postoperative eye protection, Joshua ...

For patients for whom surgery is indicated but who are opposed to undergoing glaucoma surgery, he may suggest a different ...

Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...

For optometrists, 2026 provides ample opportunity to continue the charge in advancements in dry eye, artificial intelligence ...

FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...

Data estimates the prevalence of glaucoma currently is almost 50% higher than previously estimated and over 1.6 million ...

Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...